Medication info
Synergex Semi Tablet

Synergex Semi Tablet

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›18.75mg / 1 tabletAcetaminophen›162.5mg / 1 tablet
Manufacturer / importer
Samjin Pharmaceutical Co., Ltd.
Appearance
Pale yellow oval film-coated tablet
Packaging
100 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 201309439 · Approved 2013.09.26 · Insurance code 647803860

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Elderly Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to elderly patients aged 75 years or older, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this drug after dialysis to maintain analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older and adults: The recommended initial dose is 4 tablets. Thereafter, doses should be given at intervals of at least 6 hours, and the total daily dose should not exceed 16 tablets.

Ingredients

Manufacturer
Samjin Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute pain
  • chronic pain
View approved original text

This medication is used to alleviate moderate to severe acute and chronic pain.

How to take

Adult dose

Elderly Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to elderly patients aged 75 years or older, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this drug after dialysis to maintain analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older and adults: The recommended initial dose is 4 tablets. Thereafter, doses should be given at intervals of at least 6 hours, and the total daily dose should not exceed 16 tablets.

Precautions

This drug may put strain on the liver, so individuals who regularly consume large amounts of alcohol daily should consult a doctor or pharmacist before taking it. This drug may rarely cause serious skin allergic reactions, so if skin rash or hypersensitivity reactions occur, discontinue use immediately. The tramadol component may increase the risk of seizures, so caution is required for those with a history of seizures or those taking other medications that may provoke seizures. For patients with compromised respiratory function or acute asthma, this drug may cause severe respiratory depression and should be administered only in a professional medical setting. Taking this drug with alcohol or central nervous system depressants can result in severe sedation and respiratory depression, and in severe cases, coma or death, so co-administration should be avoided. Patients with head injuries or brain diseases may have a risk of side effects such as increased intracranial pressure when taking this drug, so it should be used cautiously. This drug can lead to psychological and physical dependence, so monitoring for dependence is necessary with long-term use. Especially for patients with impaired liver function, the main ingredients of this drug, acetaminophen and tramadol, can burden the liver, so it should only be taken after consulting with a doctor. In children, especially those under 12 years old or post-operative children, this drug should not be administered, and adolescents should avoid use if there are risk factors. Pregnant or breastfeeding women should decide on the use of this drug after consulting a specialist, as it may pose risks to the fetus or newborn. Caution is required while driving or operating machinery as drowsiness or dizziness may occur. In case of overdose, severe respiratory depression, seizures, liver damage, and life-threatening symptoms can occur, so the prescribed dosage must be strictly adhered to, and if overdose is suspected, seek medical attention immediately. This drug should be stored out of reach of children and not shared with others.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reaction, respiratory depression, deep sedation, coma, hepatotoxicity, hyponatremia, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, nervousness, emotional instability, euphoria, decreased libido, sleep disturbances, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, somnolence, sensory loss, tremors, paresthesia, attention deficit, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, pupil constriction, vertigo, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, diaphoresis, urinary disorders, erectile dysfunction, weakness, chest pain, abnormal emotions, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, heat sensation, weight loss, increased blood creatinine, anaphylaxis reaction, Stevens-Johnson syndrome, toxic epidermal necrolysis, unstable emotions, delirium, suicidal ideation, muscle hypertonia, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, blood disorders, thrombocytopenia, anemia, decreased hemoglobin, decreased red blood cells, leukopenia, leukocytosis, congestive heart failure, weakness, fever, edema, rigidity, syncope, confusion, exacerbation of migraine, involuntary muscle contractions, exercise-induced dyspnea, cough, bronchitis, urinary retention, frequent urination, abnormal kidney function tests, oliguria, increased sweating, urticaria, dysphagia, tongue swelling, increased salivation, advancement of rectal cancer, advancement of esophageal cancer, advancement of gastric cancer, paralytic ileus, hiccups, cholecystitis, drowsiness, insomnia, loss of appetite, anxiety, depression, nervousness, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, leukopenia, leukocytosis, thrombocytopenia, palpitations, hypertension, arrhythmia, tachycardia, exacerbation of hypertension, aortic stenosis, gastrointestinal bleeding, elevated cholesterol, weight loss, tinnitus, chills, pain in the hips, pain in the thighs, allergic rhinitis, nosebleeds, abnormal vision, advancement of biliary cancer, foreign body sensation in the eyes, advancement of liver cancer, abnormal liver function, nausea, dizziness, dyspnea, confusion, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, vomiting, dyspepsia, confusion, multiple organ failure, anaphylaxis, intentional overdose, belching, chest discomfort, anxiety, diaphoresis, rigidity, pain, diarrhea, upper respiratory tract syndrome, increased appetite, agitation, nervousness, hyperactivity, gastrointestinal symptoms, panic attacks, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system reactions, urticaria, rash, bronchospasm, toxic skin necrosis, opioid-induced hyperalgesia, withdrawal symptoms, acute or chronic adrenal insufficiency, severe abdominal pain, hypotension, extreme fatigue, loss of appetite, weight loss, QT prolongation, respiratory depression, somnolence, coma, myocardial infarction, death

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container to prevent air and moisture from entering, and it is advisable to keep it at room temperature between 1 degree and 30 degrees Celsius. This will help maintain the drug's effectiveness.

Appearance and packaging

Appearance

Pale yellow oval film-coated tablet

Package unit

100 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.